References
- Kater CE, Biglieri EG. Disorders of steroid 17 alpha-hydroxylase deficiency. Endocrinol Metab Clin North Am. 1994;23(2):341–357.
- Auchus RJ. The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin North Am. 2001;30(1):101–119.
- Yanase T, Simpson ER, Waterman MR. 17 alpha-Hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev. 1991;12(1):91–108.
- Auchus RJ. Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic. J Steroid Biochem Mol Biol. 2017;165(Pt A):71–78.
- Chung BC, Picado-Leonard J, Haniu M, et al. Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc Natl Acad Sci USA. 1987;84(2):407–411.
- Costa-Santos M, Kater CE, Dias EP, et al. Two intronic mutations cause 17-hydroxylase deficiency by disrupting splice acceptor sites: direct demonstration of aberrant splicing and absent enzyme activity by expression of the entire CYP17 gene in HEK-293 cells. J Clin Endocrinol Metab. 2004;89(1):43–48.
- Qiao J, Hu RM, Peng YD, et al. A complex heterozygous mutation of His373Leu and Asp487-Ser488-Phe489 deletion in human cytochrome P450c17 causes 17alpha-hydroxylase/17,20-lyase deficiency in three Chinese sisters. Mol Cell Endocrinol. 2003 ;201(1-2):189–195.
- Bhangoo A, Aisenberg J, Chartoffe A, et al. Novel mutation in cytochrome P450c17 causes complete combined 17alpha-hydroxylase/17,20-lyase deficiency. J Pediatr Endocrinol Metab. 2008 ;21(2):185–190.
- Hwang DY, Hung CC, Riepe FG, et al. CYP17A1 intron mutation causing cryptic splicing in 17α-hydroxylase deficiency. PLOS One. 2011;6(9):e25492.
- Suzuki Y, Nagashima T, Nomura Y, et al. A new compound heterozygous mutation (W17X, 436 + 5G -> T) in the cytochrome P450c17 gene causes 17 alpha-hydroxylase/17,20-lyase deficiency. J Clin Endocrinol Metab. 1998;83(1):199–202.
- Yamaguchi H, Nakazato M, Miyazato M, et al. A 5'-splice site mutation in the cytochrome P450 steroid 17alpha-hydroxylase gene in 17alpha-hydroxylase deficiency. J Clin Endocrinol Metab. 1997 ;82(6):1934–1938.
- Padgett RA, Grabowski PJ, Konarska MM, et al. Splicing of messenger RNA precursors. Annu Rev Biochem. 1986;55:1119–1150.
- Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet. 1992;90(1–2):41–54.
- Costa-Santos M, Kater CE, Auchus RJ. Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency. J Clin Endocrinol Metab. 2004;89(1):49–60.
- Kim YM, Kang M, Choi JH, et al. A review of the literature on common CYP17A1 mutations in adults with 17-hydroxylase/17,20-lyase deficiency, a case series of such mutations among Koreans and functional characteristics of a novel mutation. Metab Clin Exp. 2014;63(1):42–49.
- Ogawa K, Hara A, Tanabe S, et al. A case of 17 alpha-hydroxylase deficiency syndrome associated with right adrenal tumor. Clin Exp Hypertens A. 1984;6(4):863–877.